Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human GUCY1A1 Protein, N-His

Catalog #:   YHF91701 Specific References (27) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q02108
Protein length: Gln468-Asp690
Overview

Catalog No.

YHF91701

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gln468-Asp690

Predicted molecular weight

26.76 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q02108

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Guanylate cyclase soluble subunit alpha-1, GCS-alpha-1, 4.6.1.2, Guanylate cyclase soluble subunit alpha-3, GCS-alpha-3, Soluble guanylate cyclase large subunit, GUCY1A1, GUC1A3, GUCSA3, GUCY1A3

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human GUCY1A1 protein
References

Soluble Guanylate Cyclase Dysfunction and Nitric Oxide Pathway in Chronic Rhinosinusitis With Nasal Polyps: Predictive Markers for Postoperative Recurrence., PMID:39473384

Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion., PMID:39251867

Integrated single-cell and bulk RNA sequencing identifies POSTN as a potential biomarker and therapeutic target for rheumatoid arthritis., PMID:39067546

Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma., PMID:38179743

Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy., PMID:36941667

FoxO4 controls sGCβ transcription in vascular smooth muscle., PMID:35089807

sGC Activity and Regulation of Blood Flow in a Zebrafish Model System., PMID:33716783

Novel ACE Inhibitory Peptides Derived from Yeast Hydrolysates: Screening, Inhibition Mechanisms and Effects on HUVECs., PMID:33593053

Higher susceptibility to heme oxidation and lower protein stability of the rare α1C517Yβ1 sGC variant associated with moyamoya syndrome., PMID:33571505

Moyamoya Disease 6 with Achalasia Due to GUCY1A3 Mutation in a Child., PMID:33109895

Associations between GUCY1A3 genetic polymorphisms and large artery atherosclerotic stroke risk in Chinese Han population: a case-control study., PMID:31883534

Soluble guanylyl cyclase α1 subunit is a key mediator of proliferation, survival, and migration in ECC-1 and HeLa cell lines., PMID:31616026

Variability in aspirin efficacy: all in the genes?, PMID:31280284

Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin., PMID:31228190

Genetic influences on aspirin response in patients undergoing percutaneous coronary intervention., PMID:31049556

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention., PMID:30768153

Differential expression of alternative transcripts of soluble guanylyl cyclase, GYCY1a3 and GUCY1b3 genes, in the malignant and benign breast tumors., PMID:30597209

Mechanical pressure unloading therapy reverses thoracic aortic structural and functional changes in a hypertensive rat model., PMID:30045361

Targeting transcriptional control of soluble guanylyl cyclase via NOTCH for prevention of cardiovascular disease., PMID:29754438

Cocoa procyanidins modulate transcriptional pathways linked to inflammation and metabolism in human dendritic cells., PMID:29714395

Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling., PMID:28982690

Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells., PMID:27515988

Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants., PMID:27342234

RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance., PMID:27128593

Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension., PMID:26777256

Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway., PMID:20663985

Effect of paraquat exposure on nitric oxide-responsive genes in rat mesencephalic cells., PMID:20388547

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human GUCY1A1 Protein, N-His [YHF91701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only